Acute Lymphoblastic Leukemia: Symptoms, Causes, Treatment

Subtypes differ by cell lineage and genetic features. Childhood protocols do not automatically suit every adult; response and residual-disease measurements help guide care beyond symptom improvement.

Related reading: Distinguishing acute myeloid leukemia.

Fever, pallor, fatigue, bruising, bleeding, bone pain, enlarged lymph nodes or abdominal swelling and recurrent infection may occur. Symptoms warrant assessment but do not establish leukemia on their own.

Genetic changes allow immature lymphoid cells to multiply and crowd out healthy blood cells. The individual cause is often unknown, and the disease is not contagious.

ALL is commonest in children but occurs at any age. Some cases relate to inherited syndromes or prior cancer treatment; most cannot be attributed to a particular patient or parental action.

Testing examines blood, marrow, cell markers and genetics. Spinal fluid may be assessed when appropriate and safe. Results guide subtype classification, relapse-risk assessment and follow-up.

Phased care may combine chemotherapy, corticosteroids, targeted or immune treatments and central nervous system preventive therapy. Transplantation or cellular therapies are selected for particular situations, not every patient.

Infection, bleeding, anemia and metabolic disturbances can complicate disease or treatment, and relapse is possible. Cure likelihood varies with age, subtype and response; no universal guarantee applies.

Most cases cannot be prevented by a known measure. Follow infection precautions, nutrition and monitoring plans during treatment; discuss vaccines, fertility and late effects with the team.